Mulberroside F improves airway hyperresponsiveness and inflammation in asthmatic mice
Open Access
- 11 October 2023
- journal article
- research article
- Published by Wiley in The Kaohsiung Journal of Medical Sciences
- Vol. 39 (12) , 1213-1221
Abstract
Mulberroside F is isolated from the leaves and roots of Morus alba L. Here, we investigated whether mulberroside F could alleviate airway inflammation and eosinophil infiltration in the lungs of asthmatic mice. We also examined whether mulberroside F attenuated inflammatory responses in human tracheal epithelial BEAS‐2B cells. Female BALB/c mice were sensitized and challenged with ovalbumin (OVA), and administered different doses of mulberroside F via intraperitoneal injection. Additionally, tumor necrosis factor (TNF)‐α‐stimulated BEAS‐2B cells were treated with various doses of mulberroside F, followed by detection of the expressions of inflammatory cytokines and chemokines. The results demonstrated that mulberroside F mitigated the levels of proinflammatory cytokines and chemokines, and CCL11, in inflammatory BEAS‐2B cells. Mulberroside F also suppressed reactive oxygen species (ROS) production and ICAM‐1 expression in TNF‐α‐stimulated BEAS‐2B cells, which effectively suppressed monocyte cell adherence. In an animal model of asthma, mulberroside F treatment attenuated airway hyperresponsiveness, eosinophil infiltration, and goblet cell hyperplasia. Mulberroside F treatment also decreased lung fibrosis and airway inflammation in OVA‐sensitized mice. Moreover, mulberroside F significantly reduced expressions of Th2‐associated cytokines (including interleukin(IL)‐4, IL‐5, and IL‐13) in bronchoalveolar lavage fluid compared to OVA‐sensitized mice. Our results confirmed that mulberroside F is a novel bioactive compound that can effectively reduce airway inflammation and eosinophil infiltration in asthmatic mice via inhibition of Th2‐cell activation.Keywords
Funding Information
- Chang Gung Memorial Hospital, Linkou (CMRPF1K0083, CMRPF1M0021, CMRPF1M0062, CMRPF1M0122, CMRPF1L0062)
- National Science and Technology Council (109‐2320‐B‐255 ‐002 ‐MY3)
This publication has 38 references indexed in Scilit:
- Airways exudation of plasma macromolecules: Innate defense, epithelial regeneration, and asthmaJournal of Allergy and Clinical Immunology, 2019
- Epithelial barrier repair and prevention of allergyJournal of Clinical Investigation, 2019
- Involvement and Possible Role of Eosinophils in Asthma ExacerbationFrontiers in Immunology, 2018
- Effects of Mulberry Fruit (Morus alba L.) Consumption on Health Outcomes: A Mini-ReviewAntioxidants, 2018
- Targeted anti-IL-13 therapies in asthma: current data and future perspectivesExpert Opinion on Investigational Drugs, 2018
- Biomarkers for severe eosinophilic asthmaJournal of Allergy and Clinical Immunology, 2017
- Airway Hyperresponsiveness in Asthma: Measurement and Clinical RelevanceThe Journal of Allergy and Clinical Immunology: In Practice, 2017
- Xia-Bai-San inhibits lipopolysaccharide-induced activation of intercellular adhesion molecule-1 and nuclear factor-kappa B in human lung cellsJournal of Ethnopharmacology, 2009
- Blockade of Inflammation and Airway Hyperresponsiveness in Immune-sensitized Mice by Dominant-Negative Phosphoinositide 3-Kinase–TATJournal of Experimental Medicine, 2003
- Mulberroside F Isolated from the Leaves of Morus alba Inhibits Melanin Biosynthesis.Biological and Pharmaceutical Bulletin, 2002